Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hexadecylphosphocholine differs from conventional cytostatic agents

M R Berger1, B Betsch, M Gebelein

  • 1Department of Carcinogenesis and Chemotherapy, German Cancer Research Center, Heidelberg.

Journal of Cancer Research and Clinical Oncology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a photoelectric sensor system to detect oviposition timing in individually caged broiler breeder hens.

Poultry science·2025
Same author

Preparation and evaluation of cytotoxic potential of paclitaxel containing poly-3-hydroxybutyrate-co-3-hydroxyvalarate (PTX/PHBV) nanoparticles.

Brazilian journal of biology = Revista brasleira de biologia·2023
Same author

Effects of tai chi exercise on bone health in perimenopausal and postmenopausal women: a systematic review and meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.

British journal of pharmacology·2012
Same author

Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.

Cancer gene therapy·2011
Same author

Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma.

British journal of cancer·2011
Same journal

TFE3-rearranged PEComa with hepatic and pulmonary involvement: diagnostic challenges and resistance to mTOR-targeted therapy.

Journal of cancer research and clinical oncology·2026
Same journal

GALNT5 drives colorectal cancer progression and chemoresistance via PI3K/Akt/ABCC1 axis.

Journal of cancer research and clinical oncology·2026
Same journal

Editorial Expression of Concern: Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.

Journal of cancer research and clinical oncology·2026
Same journal

Nano-biosensors for circulating tumor markers: advancing liquid biopsy toward precision cancer diagnostics.

Journal of cancer research and clinical oncology·2026
Same journal

Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients.

Journal of cancer research and clinical oncology·2026
Same journal

Stained region lymph node biopsy for axillary restaging after neoadjuvant systemic therapy in node-positive breast cancer: a cohort study.

Journal of cancer research and clinical oncology·2026
See all related articles

Hexadecylphosphocholine (HPC) demonstrates significant anticancer activity against rat mammary carcinoma, with noninvasive imaging monitoring treatment response. HPC also exhibits specific antiviral properties, suggesting a unique therapeutic profile.

Area of Science:

  • Oncology
  • Pharmacology
  • Virology

Background:

  • Alkylphosphocholines, particularly hexadecylphosphocholine (HPC), exhibit potent anticancer activity.
  • Methylnitrosourea (MNU)-induced rat mammary carcinoma serves as a model for evaluating HPC's efficacy.

Purpose of the Study:

  • To investigate the anticancer activity and therapeutic monitoring of hexadecylphosphocholine (HPC) in a rat mammary carcinoma model.
  • To explore the influence of neighboring cells on HPC's antitumor efficacy.
  • To assess the antiviral properties of HPC.

Main Methods:

  • Computed tomography and sonography for noninvasive monitoring of tumor regression.
  • Colony assays (methylcellulose and Hamburger-Salmon) to determine HPC efficacy (IC50 values).
  • Cell culture experiments to evaluate HPC's effect on tumor cell proliferation, nucleotide triphosphate levels, and virus replication.

Related Experiment Videos

Main Results:

  • HPC treatment led to significant tumor regression, observable via imaging.
  • Neighboring cells, like fibroblasts, appeared to enhance HPC's antitumor efficacy.
  • HPC demonstrated specific antiviral activity against RNA and DNA viruses at low concentrations.

Conclusions:

  • HPC exhibits significant anticancer and antiviral activities, differentiating it from conventional cytostatic agents.
  • Noninvasive imaging modalities are effective for monitoring HPC therapy in vivo.
  • Further investigation into HPC as a therapeutic agent is warranted.